A novel liposomal formulation of irinotecan comprising a combination of copper complexation and a transmembrane pH gradient to significantly improve irinotecan encapsulation and retention

Authors:

Abstract
No abstract available
Funding Information
  • Cancer Research Institute
  • Canadian Institutes of Health Research
  • Faculty of Medicine, University of British Columbia
  • Canadian Centre for Applied Research in Cancer Control
  • NanoMedicines Innovation Network

This publication has 94 references indexed in Scilit: